Please login first

The 2nd International Electronic Conference on Clinical Medicine

Chronic Diseases - Current State and Future Trends

Part of the International Electronic Conference on Clinical Medicine series
13–15 Nov 2024
Event's Timezone: Central European Time
Abstract Submission Deadline
16th August 2024
Abstract Acceptance Notification
9th September 2024

Registration Deadline
8th November 2024

Epidemiology, Immunology, Mental Health, Oncology, Hematology, Dermatology, Gastroenterology and Hepatopancreatobiliary Medicine, AI and telemedicine, Cardiology
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us Become a Sponsor

ECCM2024 is still FREE for Registration!

Register to ECCM 2024 here.

Welcome from the Chairs

Dear Colleagues,

We are pleased to announce the 2nd International Electronic Conference on Clinical Medicine: Chronic Diseases - Current State and Future Trends (ECCM 2024), which will take place online from 13 to 15 November 2024.

This conference will present the latest studies in various fields of clinical medicine. The goal is to show the current state, challenges, opportunities, and future trends.

All clinical medicine-related scientists, researchers, and individuals are welcome to join this event and share their findings pertaining to the following general and related themes, including, but not limited to, the following:

  • AI and Telemedicine;
  • Cardiology;
  • Clinical Psychology;
  • Dermatology;
  • Endocrinology and Metabolism;
  • Epidemiology and Public Health;
  • Gastroenterology and Hepatopancreatobiliary Medicine;
  • Hematology;
  • Infectious Diseases;
  • Nephrology and Urology;
  • Neurology and Stroke Neurology;
  • Nuclear Medicine and Radiology;
  • Obstetrics and Gynecology;
  • Oncology;
  • Ophthalmology;
  • Orthopedics;
  • Otolaryngology;
  • Pharmacology;
  • Psychiatry;
  • Pulmonology;
  • Stomatology.

All submitted abstracts will be reviewed by the conference committee. Following the conference, authors are welcome to submit a proceedings paper, where the publication fee will be waived. Selected contributions will be invited for submission to the journal Journal of Clinical Medicine (ISSN: 2077-0383; Impact Factor: 3.0; which ranks it 58/325 and rises from Q2 to Q1 in the category "Medicine, General & Internal"; its CiteScore 2023 is 5.7, ranking 80/636 (Q1) in "General Medicine"), with a 20% discount on the publication fee.

We look forward to you joining us at this exciting event.

Conference Chairs:
Prof. Dr. Emmanuel Andrès
Internal Medicine Department, University Hospital Strasbourg, France
Prof. Dr. Kent Doi
Department of Acute Care Medicine, University of Tokyo, Japan

Follow the conference organizer on Social Media

Program Overview

Stay tuned for the detailed program, as it will be announced soon!
Meanwhile, you can register free of charge here.

13th Morning

14th Morning

15th Morning

8:30-10:25 CET
Session 3.
Epidemiology & Public Health
9:00-11:00 CET
Session 6. Mental Health
08:30-11:15 CET
Session 1. Cardiology

13th Afternoon

14th Afternoon

15th Afternoon

13:00-15:15 CET
Session 3. Epidemiology & Public Health
13:00-16:15 CET
Session 8. Dermatology

Session 2. Gastroenterology & Hepatopancreatobiliary Medicine

14:00-16:40 CET
Session 7. Oncology & Hematology

Session 4.
AI & Telemedicine

DAY 1 Program

DAY 1

13 November 2024 (Wednesday)
Session S3. Epidemiology & Public Health (Part I)

Time: 8:30 (CET, Basel) | 03:00 (EDT, New York) | 15:30 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

8:30–8:40

Welcome from the session chair—
Dr. Francisco Guillén Grima

8:40-9:10

Prof. Dr. Jesús San Miguel Izquierdo
Keynote Speaker

TBA

9:10-9:25

Blanca Rodríguez Díaz
Selected Speaker

Using an electronic tool for hand hygiene auditing: improving data quality to lead to a better understanding of improvement measures

9:25-9:40

Giuseppe Di Buono
Selected Speaker

The First Systematic Review of the Surgical Management of Complicated Abdominal Tuberculosis—New Treatments for an Ancient Disease and the State of the Art

9:40-9:55

Krzysztof Kanecki
Selected Speaker

The effect of the COVID-19 pandemic on influenza-related hospitalization and in-hospital fatality in Poland: A nationwide register-based study

9:55-10:10

Katarzyna Lewtak
Selected Speaker

Meeting the health needs of people fleeing Ukraine: Evidence from the Polish Nationwide General Hospital Morbidity Study, 2022–2023

10:10-10:25

Evangelos Sdogkos Selected Speaker

Mandatory Rules as a Public Health Measure: A Study on Cardiac Patients With Recent Acute Coronary Syndrome

Session S3. Epidemiology & Public Health (Part II)

Time: 13:00 (CET, Basel) | 8:00 (EDT, New York) | 20:00 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

13:00-13:10

Welcome from the session chair—
Dr. Francisco Guillén Grima

13:10-13:30

Prof. Nadav Davidovitch
Invited Speaker

From epidemiology to policy: Vaccinations and inequalities as a case study

13:30-13:45

Alisa Pautova
Selected Speaker

Aromatic microbial metabolites in the cerebrospinal fluid determined by gas chromatography–mass spectrometry as promising markers of secondary bacterial meningitis

13:45-14:00

Pedro Emilio Prates
Selected Speaker

Long-Term Survival Trends in Paediatric Patients with Solid Tumours in the State of São Paulo, Brazil (2000-2022): An Analytical Descriptive Epidemiological Study

14:00-14:15

Ekaterina Sorokina
Selected Speaker

Application of bacteriophages in clinical practice

14:15-14:30

Martyna Dąbrowska
Selected Speaker

Hospitalizations of patients with atrial fibrillation (AF) in Poland: a nationwide study based on over one million AF hospitalizations in 2017-2021

14:30-14:45

Georgia Petra
Selected Speaker

Surgical Site Infections After Major Abdominal Surgery in Greece: Results of a Nationwide Multicentre Study

14:45-15:00

Renata Borys
Selected Speaker

Effect of health education on rehabilitation outcomes in patients hospitalized for SARS-CoV-2 virus infection

15:00-15:15

Rabbani Daoud
Selected Speaker

Occupational Interdigital Pilonidal Sinus among Hairdressers and Barbers in Bahrain: A Cross-Sectional Study

DAY 2 Program

DAY 2

14 November 2024 (Thursday)

Session S6. Mental Health

Time: 9:00 (CET, Basel) | 03:00 (EDT, New York) | 15:30 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

9:00-9:10

Welcome from the Scientific Committee Member —
Professor Napoleon Waszkiewicz

9:10-9:40

Dr. Marco Carotenuto
Keynote Speaker

TBA

9:40-10:00

TBA

TBA

10:00-10:15

Mauricio Barrera-Valencia
Selected Speaker

Sleep Quality and Cognitive Impairments in Children and Adolescents with PTSD Symptoms

10:15-10:30

Jose Joaquin Merino Selected Speaker

CX3CL1 delta chemokine is a chronic inflammatory mediator that links periodontitis with Alzheimer disease in patients

10:30-10:45

Alvaro Gonzalez
Selected Speaker

Impact of Substance-Use Disorder on Memory in Patients With Schizophrenia Under Treatment

10:45-11:00

Angelia Maleah Holland-Winkler
Selected Speaker

The relationship between heart rate variability and psychological outcomes in firefighters

Session S8. Dermatology

Session S2. Gastroenterology & Hepatopancreatobiliary Medicine

Time: 13:00 (CET, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

13:00-13:10

Welcome from the Session Chair (Session 8)
Dr. Alan Bernard Fleischer Jr.

13:10-13:40

Assoc. Prof. Marie Loh
Keynote Speaker

Epigenome-wide association study of skin physiology measures in a multi-ethnic Asian population

13:40-14:10

Dr. Gudula Kirtschig
Keynote Speaker

An up-date of Lichen sclerosus

14:10-14:25

Sara Goncalves
Selected Speaker

Prevalence and Impact of Skin Disorders in Palliative Care: A Systematic Review

14:25-14:40

Lyudmyla Susla
Selected Speaker

Recent Advancements in 3D Bioprinting for Pediatric Burn Treatment

14:40-14:50

Welcome from the Session Chair (Session 2)
Prof. Dr. Andrew Day

14:50-15:10

Prof. Dr. Andrew Day
Invited Speaker

TBA

15:10-15:30

Davide Ribaldone
Invited Speaker

Concomitant Immune-Mediated Inflammatory Diseases

15:30-15:45

Nina Huynh
Selected Speaker

The Role of AI-Enhanced Optical Coherence Tomography in the Early Detection and Treatment of Gastrointestinal Cancers

15:45-16:00

Giorgios Giannos
Selected Speaker

Safety, feasibility and preliminary results of a multicenter randomized trial comparing fat-free versus balanced (WHO) diet in gallstone disease (The Rationale Diet for Gallstones (RADIGAL) study)

16:00-16:15

Aparna Naik
Selected Speaker

Genetic Variations and Drug Response in Gastroesophageal Reflux Disease (GERD): The Role of Pharmacogenomic Testing in Optimizing Proton Pump Inhibitor (PPI) Therapy

DAY 3 Program

DAY 3

15 November 2024 (Friday)
Session S1. Cardiology

Time: 8:30 (CET, Basel) | 03:00 (EDT, New York) | 15:30 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

8:30-8:40

Welcome from the session chair—
Dr. Karl-Philip Rommel

8:40-9:10

Prof. Dr. Richard Sutton
Keynote Speaker

Syncope: New Approaches

9:10-9:40

TBA

TBA

9:40-10:00

Dr. Mauro Feola
Invited Speaker

Impact of drugs on cardiovascular mortality and sudden cardiac death

10:00-10:15

Srdjan Nikolovski
Selected Speaker

Comparison of Novel vs. Standard Myocardial Dysfunction Biomarkers and Analysis of Their Relation With Diastolic Dysfunction Grade in Kidney Transplant Recipients

10:15-10:30

Sriya N. Kakarla
Selected Speaker

An insight into the Interplay between Immune Thrombocytopenic Purpura (ITP) and Heart Failure: A Retrospective Analysis of National Inpatient Data in the United States

10:30-10:45

Lilia Sabantina and Patrizia Zimmermann Selected Speakers

Optimizing Pattern Design and Standardizing Production for Abdominal Aortic Prostheses

10:45-11:00

Michael Bonios
Selected Speaker

Left ventricular assist devices as a bridge to transplant strategy in a low organ donation environment: Single-center experiences

11:00-11:15

Yongting Luo
Selected Speaker

The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture

Session S7. Oncology & Hematology
Session S4. AI & Telemedicine

Time: 14:00 (CET, Basel) | 08:00 (EDT, New York) | 21:00 (CST Asia, Beijing)

CET (Central European Time)

Speaker

Title

14:00-14:10

Welcome from the Session Chair (Session 7)
Prof. Dr. Alex C. Spyropoulos

14:10-14:30

Dr. Helen Papadaki
Invited Speaker

New insights in chronic idiopathic neutropenia
of adults
14:30-14:50

Assoc. Prof. Luigi Marano
Invited Speaker

TBA

14:50-15:05

Maciej Dubaj
Selected Speaker

Small molecules of great importance

15:05-15:20

Hamzah Adwan
Selected Speaker

The Combination Therapy of Transarterial Chemoembolization and Microwave Ablation Leads to Better Survival for Liver Metastases from Colorectal Cancer: A Comparative Study

15:20-15:35

Nikoleta Bizymi
Selected Speaker

Inflammageing: increase in polymorphonuclear myeloid-derived suppressor cells in aged healthy individuals

15:35-15:50

Jayashabari Shankar Selected Speaker

Advancing Cancer Research with Graph Neural Networks: A Comparative Study of Neural Network Architectures for Multi-Omics Data Integration and Interpretation

15:50-16:00 Welcome from the Session Chairs (Session 4)
Dr. Carlos Escobar Cervantes and Assoc. Prof. Koroush Kabir
16:00-16:15 Sabrina Benghida
Selected Speaker
Transformative Impact of Telemedicine on Healthcare in South Korea: A Systematic Review
16:15-16:30 TBA TBA
16:30-16:40

Dr. Connie Y. Chang
Invited Speaker

Challenges of Artificial Intelligence (AI) in radiology, with a Focus on Musculoskeletal Oncology

Event Chairs

Internal Medicine Department, University Hospital Strasbourg, 67081 Strasbourg, France

Introduction
Bio
Dr. Emmanuel Andrès is Editor-in-Chief of JCM since 2018. He is very active and knows the journal very well. He has a good reputation and has published more than 600 papers (H-index of 47 on Scopus). His research interests are drug-induced cytopenias, anemia, thrombocytopenia, neutropenia, cobalamin deficiency, vitamin B12 deficiency, telemedicine, chronic diseases, and chronic heart failure.

Department of Acute Care Medicine, University of Tokyo, Tokyo 113-8654, Japan

Introduction
Bio
Kent Doi, M.D., Ph.D. is Professor of Medicine in the department of Emergency and Critical Care Medicine at The University of Tokyo, Japan. He received his M.D. and Ph.D. at the University of Tokyo followed by research nephrology training at NIH/NIDDK. At the University of Tokyo, Dr. Doi is currently a clinical and basic research investigator. His research interests include acute kidney injury, sepsis, and multiple organ failure. His research involves AKI biomarker, sepsis-induced AKI, and organ system network analysis in multiple organ failure. Dr. Doi is a council member of the Japanese Society of Intensive Care Medicine, Fellow of the Japanese Society of Internal Medicine (FJSIM), Councilor and Board-Certified Nephrologist of the Japanese Society of Nephrology, Board Certified Senior Member of the Japanese Society for Dialysis Therapy. Dr. Doi has published over 250 scientific articles and has delivered over 20 presentations at scientific meetings. He is an Associate Editor for multiple journals.

Session Chairs

Dr. Karl-Philip Rommel

Department of Cardiology, Heart Center Leipzig at University of Leipzig, 04289 Leipzig, Germany

Introduction
Bio
https://tvt2023.crfconnect.com/faculty/Karl-Philipp-Rommel-12998
Session
S1. Cardiology

Dr. Francisco Guillén Grima

1. Department of Preventive Medicine, Clinica Universidad de Navarra, University of Navarra, Spain; 2. Navarra Medical Research Institute (IdiSNA), Spain; 3. Center for Biomedical Research Network Epidemiology and Public Health, (CIBERESP), Spain; 4. Department of Health Sciences, Public University of Navarra, Spain

Introduction
Bio
Dr. Francisco Guillen-Grima is a renowned Spanish physician and academic specializing in Preventive Medicine and Public Health. He earned his MD, PhD, and MBA from the University of Murcia and furthered his studies at Harvard University, obtaining an MPH and MSc in Epidemiology. His career includes roles such as Medical Officer in Murcia, Fulbright Scholar at Harvard, and Field Epidemiologist in Pamplona. Since 2005, he has been the Head of Preventive Medicine at the University of Navarra Clinic and a Full Professor at the Public University of Navarra. Dr. Guillen-Grima has also served as the director of several graduate programs and held advisory positions at ANECA. His leadership extended to serving as the Secretary of the Spanish Society of Preventive Medicine, Public Health, and Hygiene. His career is distinguished by his commitment to advancing public health education and policy.
Session
S3. Epidemiology & Public Health

Assoc. Prof. Michele Roccella

Department of Psychology, Educational Science and Human Movement, University of Palermo, 90128 Palermo, Italy

Introduction
Bio
https://www.unipa.it/persone/docenti/r/michele.roccella
Session
S6. Mental Health

Dr. Alan Bernard Fleischer Jr.

Department of Dermatology, University of Cincinnati, 3230 Cincinnati, OH 45267, USA

Introduction
Bio
Alan Fleischer is a professor and residency program director at the University of Cincinnati College of Medicine. In addition to clinical work, he has been involved as an investigator with hundreds of clinical trials and hundreds of health services research studies.
Session
S8. Dermatology

Prof. Dr. Alex C. Spyropoulos

1. Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA; 2. Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY 10075, USA; 3. The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA; 4. Elmezzi Graduate School of Molecular Medicine, Manhasset, NY 11030, USA

Introduction
Bio
MD, FACP, FCCP, FRCPC
Session
S7. Oncology & Hematology

Dr. Carlos Escobar Cervantes

Cardiology Department, University Hospital La Paz, 28046 Madrid, Spain

Introduction
Bio
Cardiologist, coordinator of clinical cardiology and continuity of care with Primary Care, University Hospital La Paz, Madrid, Spain. Coordinator of automation of the vascular risk process of the Community of Madrid, Spain. Scientific coordinator of the DTX consortium. Past-member of the Executive Committee of the Investigation Agency of the Spanish Society of Cardiology. Past-president of the Clinical Cardiology group of the Spanish Society of Cardiology. Member of the European Society of Cardiology (ESC). Member of the Cardiovascular Pharmacology and Drug Therapy Working Group of ESC. Member of the Council of Cardio-Oncology Regular of ESC. Member of the Council of Stroke Regular of ESC. Member of the Spanish Society of Cardiology. Member of the International Lipid Expert Panel. Member of the working group of hypertension and cardiovascular disease of SEMERGEN (Spain). Referee of several national and international peer-review journals. Participation in several clinical trials and investigation projects in the fields of hypertension, heart failure, atrial fibrillation, acute coronary syndrome, pulmonary embolism and cardiometabolic disease. Over 400 papers published in national and international peer-review journals and over 50 chapters in Cardiology textbooks.
Session
S4. AI & Telemedicine

Dr. Ariela Hoxha

Internal Medicine Unit, Thrombotic and Hemorrhagic Center, Department of Medicine, University of Padua, 35122 Padova, Italy

Introduction
Bio
Dr. Ariela Hoxha, M.D., PhD, is a rheumatologist and senior consultant in Internal Medicine at the Center for Thrombotic and Hemorrhagic Diseases, Department of Medicine, University of Padua. Her clinical research focuses on systemic thrombo-inflammatory and autoimmune diseases, particularly with a focus on antiphospholipid antibody syndrome and connective tissue diseases. She is an ordinary member of national and international scientific societies and actively participates in national and international study groups on the study of systemic autoimmune diseases.
Session
S5. Immunology

Assoc. Prof. Koroush Kabir

Department of Trauma Surgery, Orthopaedics & Sports Medicine, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany

Introduction
Bio
-
Session
S4. AI & Telemedicine

Prof. Dr. Andrew Day

Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand

Introduction
Bio
-
Session
S2. Gastroenterology & Hepatopancreatobiliary Medicine

Event Committee

Department of Computer Science, Ostfalia University of Applied Sciences, Germany,
Biostatistics Group, Helmholtz Centre for Infection Research, Germany

Introduction
Research Keywords
exploratory data analysis, data visualisation, robust and computational statistics. He is a member of the editorial board of international journals like Data Mining, Modelling & Management (IJDMMM), Intelligent Data Analysis (IDA) and Evolving Systems (ES

Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Greece,
Unit of Endocrinology, Diabetes and Metabolism, School of Medicine, National and Kapodistrian University of Athens, Aretaieion Hospital, Greece

Introduction
Research Keywords
immunologic pathways of stress, the role of gut microbiome. and the impact of stress on human body composition

Animal Facility and Animal Experimentation Unit, Biocruces Bizkaia Health Reseach Institute, Spain

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, USA

School of Medicine, European University Cyprus, Nicosia

Department of Internal Medicine A, Division of Cardiology, Angiology, Nephrology and Intensive Medical Care, University Hospital Ruppin-Brandenburg (UKRB) of the Medical School of Brandenburg,
Medical Faculty, Martin Luther-University Halle-Wittenberg, Magdeburger Strasse 8, D-06112 Halle (Saale), Germany

Department of Public Health, School of Medicine, University of Patras, University Campus, Greece

Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand

Hematology Unit and Bone Marrow Transplant, A.O.U. Policlinico “G. Rodolico—San Marco”, 95123 Catania, Italy

1. Department of Clinical Psychology and Psychobiology, University of Barcelona, 08035 Barcelona, Spain; 2. Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain

BioImmuno Designs, Inc., Edmonton AB T5J 4P6, Canada

School of Medicine, University of Crete, 71500 Heraklion, Greece

Department of Public Health and Maternal & Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain

Department of Psychiatry, Medical University of Białystok, Wołodyjowskiego 2 Str., 15-272 Białystok, Poland

Department of Internal Medicine and Rheumatology, Spitalul Clinic Sfanta Maria, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania

Department of Haematology, Cancer Institute, University College of London, Paul O'Gorman Building, London WC1E 6BT, UK

Heart Failure, Transplant and Mechanical Circulatory Support Units, Onassis Cardiac Surgery Center, 17674 Athens, Greece

1. Hospital Universitario Virgen de las NIeves, 18014 Granada, Spain; 2. Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain

Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, św. Anny 12, 31-007 Krakow, Poland,
The St. John Paul II Hospital, Krakow 31-202, Poland

Department of Dermatology, Rambam Health Care Campus, Haifa 3109601, Israel

Faculty of Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan

Department of Surgery and Cancer, Imperial College Healthcare NHS Trust, London W12 0HS, UK

The Bristol Immunology and Allergy Centre, North Bristol NHS Trust, Bristol BS10 5NB, UK

Department of Medicine, Academy of Applied Medical and Social Sciences, Akademia Medycznych I Spolecznych Nauk Stosowanych (AMiSNS), 2 Lotnicza Street, 82-300 Elbląg, Poland,
Department of General Surgery and Surgical Oncology, “Saint Wojciech” Hospital, “Nicolaus Copernicus” Health Center, Jana Pawła II 50, 80-462 Gdańsk, Poland

Introduction
Bio
Dr. Luigi Marano is a Professor of Surgery at the Department of Medicine, Academy of Applied Medical and Social Sciences (AMiSNS) in Elbląg, Poland. He also serves as the supervisor of the Robotic and Advanced Minimally Invasive Surgical Program at the Department of General Surgery and Surgical Oncology, located at “Saint Wojciech” Hospital within the “Nicolaus Copernicus” Health Center in Gdańsk, Poland. In 2014, he attained the title of Specialist in General Surgery with top marks and honors. Throughout his academic career, Dr. Marano has demonstrated a keen interest in esophago-gastric surgery and oncological surgery, leading him to pursue a second-level University Master’s degree in “Oncological Digestive Surgery” at the Catholic University of the Sacred Heart in Rome in 2013. Since 2021, he has held the position of Permanent Associate Professor at the same department. Dr. Marano is a prolific author, with numerous scientific articles and book chapters published internationally, covering various topics within esophageal and stomach surgery, as well as oncological surgery. He currently serves as a member of the “Education and Training Committee-Upper-GI section” of the European Society of Surgical Oncology (ESSO). Additionally, from 2019 to 2020, he held the position of National Coordinator of the Italian Society of Oncological Surgery-Young (YSICO).

Department of Physiopathology and Transplantation, University of Milan, 20122 Milan, Italy,
Dermatology Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy

Medicine and Oral Surgery Service and UNIPRO Research Unit (Director), University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal

Department of Internal Medicine, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania

Keynote Speakers

Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, University of Campania “Luigi Vanvitelli”, 81100 Caserta, Italy

Cancer Center Clinica Universidad de Navarra (CCUN), CIMA, IDISNA, 31008 Pamplona, Spain

Introduction
Bio
Jesús San-Miguel is Professor of Medicine-Hematology , currently Senior Consultant and Strategic Advisor at the Cancer Center of Clinica Universidad de Navarra in Spain. For the past 10 years he has served at this institution as Director of Clinical and Translational Medicine. He was Director of the Hematology Department of the University Hospital of Salamanca in Spain, for more than 2 decades, also has served as Director of the Biomedical Research Institute of Salamanca and Vice Director of the Cancer Research Center. He was President of the International Myeloma Society from 2012 until 2019. Professor San-Miguel has published extensively (over 900 original papers, H-Index: 148 and >100.000 citations) and has made seminal contributions to myeloma cell biology in areas such as immunophenotyping, risk of progression from monoclonal gammopathy of undetermined significance or smouldering MM into active MM, and minimal residual disease and therapeutics, including studies for new antimyeloma drugs at the preclinical and clinical levels (5 drugs/combinations approved by FDA/EMA under his leadership) Dr San Miguel´s reputation has been recognized by more than 30 Research Awards and Honors, such as: the Waldenstrom Award, the Kyle Life Achievement Award, the EHA-Carreras Award, the Thomas H. Ham-Wasserman Lecture Award, the Michaelli Award, the KNAW Bob Pinedo Award, Premio Fundación Lilly, Premio Rey Jaime I and the Spanish National Prize of Medicine.

Department of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798, Singapore

Introduction
Talk
Epigenome-wide association study of skin physiology measures in a multi-ethnic Asian population
Bio
Marie Loh is an Assistant Professor in the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and a Senior Research Scientist at the Genome Institute of Singapore. She is also a Honorary Senior Lecturer at Imperial College London and Senior Research Scientist at the National Skin Centre, Singapore . Asst Prof Marie Loh is a molecular epidemiologist with a long-standing interest in the role of genetics and epigenetics underlying complex diseases, with a specific focus on ethnic differences in risk and outcome. Her current research focuses on combining population health with molecular phenotyping and laboratory-based approaches to advance knowledge and understanding in complex diseases such as atopic dermatitis.

National Heart and Lung Institute, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK

Introduction
Talk
Syncope: New Approaches
Bio
MB BS DSc FRCP FACC FESC FAHA FHRS EHRA FBHRS Richard Sutton born Newport, UK, graduated King’s College Hospital Medical School 1964. He has been Consultant Cardiologist at Westminster, Chelsea-&-Westminster, Royal Brompton and St Mary’s Hospitals, London 1976-2011, Professor of Clinical Cardiology, Imperial College, London 2003; DSc London 1988; he has published >400 peer-reviewed papers on Pacing/Syncope/Cardiology and became Emeritus Professor and Honorary Consultant Cardiologist, Hammersmith Hospital, London in 2011. He has been President British Heart Rhythm Society (was BPEG) 1990-1995 (joint Founder), President European Working Group on Cardiac Pacing 1998-2000 (now EHRA) and President of Cardiology section, Royal Society of Medicine, London, UK (joint Founder); Editor-in-Chief Europace 1998-2006, now Founding Editor (2007-present). He won Lifetime Achievement Award Heart Rhythm Congress 2007, Pioneer in Cardiac Pacing & Electrophysiology, Heart Rhythm Society, 2016. He married Jeanne-Marie Arrighi in 2014 and lives in Monaco.

Medical Health Centre Frauenfeld, Frauenfeld, Switzerland

Introduction
Talk
An up-date of Lichen sclerosus
Bio
I am a Consultant Dermatologist based in Germany and Switzerland. I studied medicine at Ulm University & Muenster University in Germany and have previously practiced dermatology in academic centres in Oxford, UK and Amsterdam, NL. I have special interest in vulval skin disease, pregnancy associated skin disease and blistering skin conditions. I have a strong research interest and my work has contributed towards the production of more than 100 peer reviewed scientific articles, national/international clinical guidelines, and patients’ information leaflets. Together with more than 20 co-authors I have edited a prize-winning book on vulval diseases. I work with the Cochrane skin group to deliver systematic reviews and sit on the oversight committees of clinical trials and I am the senior author of the European S3 guideline on Lichen sclerosus, updated in 2023. I am committed to excellence in clinical dermatology. I am a member of the Lichen Sclerosus PSP and the steering group to develop Core Outcome Sets (COS) for LS.

Invited Speakers

School of Medicine, University of Crete, 71500 Heraklion, Greece

Introduction
Bio
Helen Papadaki is a Professor of Haematology at the School of Medicine, University of Crete (UoC), Greece. She is Head of the Department of Haematology, Cell Therapy Unit and the Public Cord Blood Bank of the University Hospital of Heraklion, Crete, and Head of the Haemopoiesis Research Laboratory, UoC. Dr. Papadaki received her MD from the UoAthens with honours and her PhD from the UoC. She has been trained in Internal Medicine and Haematology at the UoC and has been post-doc researcher (EMBO fellowship) in Saint George’s Medical School, London, UK, visiting scientist at the Institute for Cancer Studies, Birmingham, UK and visiting physician at the Department of Haematology, University of Washington, Seattle, USA. Dr Papadaki has been appointed Deputy Rector of the UoC (2013-2015), has been elected as European Haematology Association (EHA) Board Member (2016 – 2020), she is now co-chairing the EHA Community and Stakeholder Committee and is a member of the EHA Good Governance Committee. She is the co-chair of the EHA Scientific Working Group on Granulocyte and Constitutional Marrow Failure Syndromes, external advisory board member of the Severe Chronic Neutropenia International Registry (SCNIR). Dr Papadaki’s main field of interest is Neutropenia, Bone Marrow Failure Syndromes and Umbilical Cord Blood applications. She had been the PI in a number of national and international Projects, she has more than 200 publications and more than 7000 citations. She has been awarded by 25 Awards for best abstract or full paper in the Hellenic Haematology Association and has received the Health Care Greek Award for the category “Research in Hospital” in 2021 and 2023.

Department of Medicine, Academy of Applied Medical and Social Sciences, Akademia Medycznych I Spolecznych Nauk Stosowanych (AMiSNS), 2 Lotnicza Street, 82-300 Elbląg, Poland,
Department of General Surgery and Surgical Oncology, “Saint Wojciech” Hospital, “Nicolaus Copernicus” Health Center, Jana Pawła II 50, 80-462 Gdańsk, Poland

Introduction
Talk
Dr. Luigi Marano is a Professor of Surgery at the Department of Medicine, Academy of Applied Medical and Social Sciences (AMiSNS) in Elbląg, Poland. He also serves as the supervisor of the Robotic and Advanced Minimally Invasive Surgical Program at the Department of General Surgery and Surgical Oncology, located at “Saint Wojciech” Hospital within the “Nicolaus Copernicus” Health Center in Gdańsk, Poland. In 2014, he attained the title of Specialist in General Surgery with top marks and honors. Throughout his academic career, Dr. Marano has demonstrated a keen interest in esophago-gastric surgery and oncological surgery, leading him to pursue a second-level University Master’s degree in “Oncological Digestive Surgery” at the Catholic University of the Sacred Heart in Rome in 2013. Since 2021, he has held the position of Permanent Associate Professor at the same department. Dr. Marano is a prolific author, with numerous scientific articles and book chapters published internationally, covering various topics within esophageal and stomach surgery, as well as oncological surgery. He currently serves as a member of the “Education and Training Committee-Upper-GI section” of the European Society of Surgical Oncology (ESSO). Additionally, from 2019 to 2020, he held the position of National Coordinator of the Italian Society of Oncological Surgery-Young (YSICO).

Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev (BGU), Beer Sheva 84105, Israel

Introduction
Bio
Prof. Nadav Davidovitch is an epidemiologist and public health physician and Head of Ben-Gurion University of the Negev’s School of Public Health. In the past, he has served as Chair of the Association of Public Health Physicians in Israel and the cabinet of the “Magen Israel” program (a national program for fighting the coronavirus). He is currently a member of various international committees including Chair of ASPHER Task Force on Public Health Emergencies. Prof. Davidovitch has authored a great many articles and books on the subject of public health, health policy, health economics, health systems management, ethics and sociology of health. Since the outbreak of COVID-19 in Israel, he has been involved in research and the formulation of health policy and has advised various agencies in Israel and abroad on the need to make structural changes in the health system, with an emphasis on social issues and addressing health gaps.

Department of Medical Sciences, University of Turin, 10126 Turin, Italy

Introduction
Bio
: Graduated in Medicine and Surgery in 2011, specialized in Gastroenterology in 2017 at University of Turin, Doctoral degree in Bioengineering and Medical-Surgical Science in 2022 (University of Turin - Polytechnic). Degree in Telecommunication Engineering in 2005 at the Polytechnic University of Turin. Associate professor at the Department of Medical Sciences and gastroenterologist consultant, head of IBD clinic at "A.O.U. Città della Salute e della Scienza di Torino" - "Molinette" hospital.

Cardiology Division Ospedale Regina Montis Regalis, Strada del Rocchetto 99, 12084 Mondovi, Italy

Introduction
Talk
Cardiac sudden death in heart failure patients
Bio
Clinical Cardiologist; Head of the Cardiology Division in Hospital Regina MOntis Regalis Mondovi' ITALY; field of interest: CV imaging; heart Failure. Authors of >100 manuscripts indexed in PubMed.

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA,
Harvard Medical School, Cambridge, MA 02115, USA

Introduction
Talk
Challenges of Artificial Intelligence (AI) in Radiology, With a Focus on Musculoskeletal Oncology
Bio
Dr. Chang graduated from MIT and Cornell Medical School, after which she completed her radiology training at Massachusetts General Hospital of Harvard Medical School. She works in the field of Musculoskeletal Imaging in Intervention, and has published more than 100 manuscripts and given more than 100 talks. Her research interests focus on Tumor, Infection and Intervention, including AI applications. To learn more about her and her work, please go to https://cychang.mgh.harvard.edu/

Registration


Registration for ECCM 2024 will be free of charge! The registration includes attendance at all conference sessions.

If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.

Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 8 November 2024.

Instructions for Authors

Instructions for Authors
The 2nd International Electronic Conference on Clinical Medicine will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.

Important Deadlines
Deadline for abstract submission: 16 August 2024
Announcement of oral and poster abstract results: 6 September 2024; You will be notified of the acceptance of an oral/poster presentation in a separate email.

Certificates of Participation are available in your logged-in area of Sciforum.net, under “My certificates” after the conference.

Abstract Submission
1. Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system. No physical submission is necessary.
2. The abstract should include an introduction, methods, results, and conclusion sections, and be about 200–300 words in length.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. All abstracts accepted for presentation will be collected in a book of abstracts, which will be published on the website after the conference.
6. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or they will not be accepted to this conference.

Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.

Oral Presentation and Slides Submission
The slot for the oral presentation is 15 minutes. We recommend a 12-minute presentation, leaving about 3 minutes for a Q&A session.

Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.

Poster Gallery
a. Your submission should include the title, authors, contact details, and main research findings, as well as tables, figures, and graphs where necessary.
b. File format: PDF (.pdf).
c. Size in cm: 60 width x 80 height–portrait orientation.
d. Font size: ≥20.
e. Maximum size: 250 M
You can use our free template to create your poster. The poster template can be downloaded here.
Authors who wish to present a poster are invited to send it to the conference email at eccm2025@mdpi.com. All posters will be

permanently exhibited online in the Poster Gallery.

Potential Conflicts of Interest
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

Copyright
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.

Publication Opportunities

- Journal of Clinical Medicine Publication
Participants in this conference are cordially invited to contribute a research article to the Special Issue, published in Journal of Clinical Medicine (ISSN: 2077-0383, Impact Factor: 3.0), with a 20% discount on the publication fee. Please note that if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Details of the special issue will be announced here later. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.

- Proceeding Paper Publication

All accepted abstracts will be published in the conference report of ECCM2024 in Medical Sciences Forum (ISSN: 2673-9992); if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference.

Authors are asked to disclose that it is a proceeding paper of the ECCM 2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.

Proceedings paper submission deadline: 31 December 2024.

Manuscripts for the proceedings issue must be formatted as follows:
  • Title.
  • Full author names.
  • Affiliations (including full postal address) and authors' e-mail addresses.
  • Abstract.
  • Keywords.
  • Introduction.
  • Methods.
  • Results and Discussion.
  • Conclusions.
  • Acknowledgements.
  • References.

Event Awards

To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.

The Awards
Best Oral Presentation Award and Best Poster Award

Number of Awards Available: 6

The Best Oral Presentation Award is given to the submission judged to make the most significant oral contribution to the conference.

The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.

There will be six winners selected for this award. The winner will receive a certificate and 200 CHF each.

Sponsors and Partners

For information regarding sponsorship and exhibition opportunities, please click here.

Organizers


Media Partners

Conference Secretariat

Ms. Niya Wu
Ms. Ioana Vintila

For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
Email: eccm2024@mdpi.com

Top